|
2023
|
Invention
|
Vasopressin formulation. The present disclosure relates to a ready-to-use formulation of vasopres... |
|
|
Invention
|
Liquid dalbavancin composition. The present disclosure relates to a stable aqueous composition of... |
|
|
Invention
|
Ready-to-administer product comprising a norepinephrine formulation. Described herein are ready-t... |
|
|
Invention
|
Oxytocin formulation. The present disclosure relates to a ready-to-administer formulation of oxyt... |
|
2022
|
Invention
|
Injectable phenylephrine compositions. Described herein is a product including a ready-to-adminis... |
|
|
Invention
|
Oral liquid vancomycin formulations. Described herein are ready to use oral liquid unit dosage fo... |
|
|
Invention
|
Synthesis process.
An optimized method for synthesizing dalbavancin is provided in which an orga... |
|
|
Invention
|
Synthesis process. An optimized method for synthesizing dalbavancin is provided in which an organ... |
|
2021
|
Invention
|
Novel compositions of beta-lactam compounds. The present invention relates to pharmaceutical comp... |
|
|
Invention
|
Stable formulations comprising piperacillin and/or tazobactam. The present invention relates to p... |
|
|
Invention
|
Ceftriaxone compositions with magnesium component. A liquid pharmaceutical composition comprising... |
|
|
Invention
|
Daptomycin formulation with branched aiphatic amino acid. The present disclosure relates to a sol... |
|
|
Invention
|
Daptomycin formulation. The present disclosure relates to a solid formulation of daptomycin compr... |
|
2020
|
Invention
|
Daptomycin aqueous formulations. The present disclosure is related to providing a stable daptomyc... |
|
2018
|
Invention
|
Daptomycin formulations. The present invention relates to compositions comprising daptomyci... |
|
|
Invention
|
Daptomycin formulations. The present invention relates to compositions comprising daptomycin and ... |
|
2017
|
Invention
|
Liquid formulations of daptomycin. The present invention relates to liquid pharmaceutical composi... |
|
|
Invention
|
Stabilized glycopeptide antibiotic formulations. Disclosed herein are liquid formulations of glyc... |
|
2016
|
Invention
|
Anidulafungin formulations. The present invention is directed to stable formulations comprising t... |
|
|
Invention
|
Polymyxin derivatives. The present invention relates to polymyxin derivatives and their use as an... |
|
2015
|
Invention
|
Glycopeptide compositions. Solutions comprising a glycopeptide antibiotic, for example Vancomycin... |
|
|
Invention
|
Inhalation device. Disclosed herein is a pulmonary administration device, comprising a spray nozz... |
|
|
Invention
|
Sulfomethylated polymixin compositions. Disclosed herein is an aqueous solution comprising from 8... |
|
|
Invention
|
Aqueous solution of colistimethate sodium. Disclosed herein is an aqueous solution comprising fro... |
|
|
Invention
|
Compositions. Disclosed herein is an aqueous solution comprising from 80 mg A/mL to 400 mg A/mL o... |
|
|
Invention
|
2-amino-3-methyl-hex-5-enoic acid and its use in the prodction of peptides such as bacitracins.
... |
|
|
Invention
|
Low substituted polymyxins and compositions thereof. The present invention relates to novel low s... |
|
|
Invention
|
Polymorphs and new solid states of tiacumicin b. The present invention relates to new polymorphs ... |
|
|
Invention
|
Polymorphs and solid states of tiacumicin b. The present invention relates to new polymorphs cons... |
|
|
Invention
|
New polymorphs and new solid states of tiacumicin b. The present invention relates to new polymor... |
|
2014
|
Invention
|
Process for the preparation of tiacumicin.
The present invention relates to the preparation of T... |
|
|
Invention
|
Process for the preparation of tiacumicin. The present invention relates to the preparation of Ti... |
|
|
Invention
|
Container system for intravenous therapy. A system for intravenous therapy is disclosed. The syst... |
|
|
Invention
|
Caspofungin composition. The present invention relates to a composition comprising caspofungin or... |
|
|
Invention
|
Characterization of colistimethate sodium (cms). The present invention regards a HPLC method usef... |
|
|
Invention
|
A method for stabilizing tigecycline. The present invention relates to a method for stabilizing T... |
|
|
G/S
|
Anti-infective pharmaceutical preparations. |
|
|
Invention
|
Polymyxins, compositions, methods of making and methods of use. 2.
|
|
|
Invention
|
Voriconazole inclusion complexes.
The present invention relates to new voriconazole formulations... |
|
2013
|
G/S
|
Pharmaceutical and veterinary preparations, including
anti-infective pharmaceutical preparations. |
|
|
Invention
|
Method of mineral leaching. supplying energy in the form of a combination of high-voltage electri... |
|
2012
|
Invention
|
Method for purification of micafungin. The present invention relates to a method for the purifica... |
|
|
Invention
|
Methods for manufacturing an antifungal agent. The present invention relates to an improved proce... |
|
2010
|
G/S
|
Chemicals used in industry and science, namely antibiotic, anti-infective, anti-viral, anti-funga... |
|
2009
|
G/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
|
|
G/S
|
Chemicals used in industry and science, namely, antibiotic, anti-infective, anti-viral, anti-fung... |
|
|
G/S
|
Chemicals used in industry, science and photography, as well
as in agriculture, horticulture and... |
|
|
G/S
|
Medical apparatus for facilitating the inhalation of
pharmaceutical preparations. |
|
|
G/S
|
Chemical used in industry, science and photography; unprocessed artificial resins, unprocessed pl... |
|
|
G/S
|
Chemicals used in industry and science; ingredients for use
in the pharmaceutical and veterinary... |
